Szymura S, Bernal G, Wu L, Zhang Z, Crawley C, Voce D, et al. DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy. BMC Biol. 2020;18:32 pubmed publisher

Tang Y, Shi G, Yang J, Zheng W, Tang J, Chen X, et al. Role of PKR in the Inhibition of Proliferation and Translation by Polycystin-1. Biomed Res Int. 2019;2019:5320747 pubmed publisher

Cheng X, Bennett R, Liu X, Byrne M, Stratford May W. PKR negatively regulates leukemia progression in association with PP2A activation, Bcl-2 inhibition and increased apoptosis. Blood Cancer J. 2013;3:e144 pubmed publisher

Zhang L, Alter H, Wang H, Jia S, Wang E, Marincola F, et al. The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells. Virology. 2013;438:28-36 pubmed publisher

Bennett R, Carruthers A, Hui T, Kerney K, Liu X, May W. Increased expression of the dsRNA-activated protein kinase PKR in breast cancer promotes sensitivity to doxorubicin. PLoS ONE. 2012;7:e46040 pubmed publisher

Sanghvi V, Steel L. The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR. J Virol. 2011;85:12614-21 pubmed publisher